Rezolute (RZLT) Net Cash Flow (2010 - 2026)
Rezolute (RZLT) posted Net Cash Flow of -$662000.0 for Q1 2026, down 123.9% sequentially from $2.8 million in Q4 2025, and down 111.69% YoY from $5.7 million in Q1 2025.
Analysis
Rezolute (RZLT) Net Cash Flow (2010 - 2026) Analysis & Trends
Rezolute has reported Net Cash Flow for 17 years, with the latest figure at -$662000.0 in Q1 2026.
- Quarterly Net Cash Flow fell 111.69% year-over-year to -$662000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.4 million (down 139.06% YoY) and the FY2025 annual result came in at $23.7 million, down 56.43% from the prior year.
- Net Cash Flow declined to -$662000.0 in Q1 2026 per RZLT's latest filing, from $2.8 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $82.0 million in Q2 2022 and troughed at -$113.0 million in Q1 2023.
- A 5-year average of -$4.2 million and a median of -$1.5 million in 2024 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2022 and 2023: Net Cash Flow jumped 805.21% in 2022, then slumped 707.91% in 2023.
- Over 5 years, Net Cash Flow stood at -$7.6 million in 2022, then soared by 162.57% to $4.7 million in 2023, then sank by 132.49% to -$1.5 million in 2024, then surged by 279.87% to $2.8 million in 2025, then plunged by 123.9% to -$662000.0 in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$662000.0, $2.8 million, and -$85.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -183.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 374.50 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 407.41 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -496,000.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 225.59 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -37.14 Mn |
| 10 | Rezolute | 477.02 Mn | 477.02 Mn | - | -673,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -673,000.00 |
| Dec 31, 2025 | 2.80 Mn |
| Sep 30, 2025 | -85.01 Mn |
| Jun 30, 2025 | 79.49 Mn |
| Mar 31, 2025 | 5.66 Mn |
| Dec 31, 2024 | -1.54 Mn |
| Sep 30, 2024 | -59.92 Mn |
| Jun 30, 2024 | 64.47 Mn |
| Mar 31, 2024 | -6.57 Mn |
| Dec 31, 2023 | 4.74 Mn |
| Sep 30, 2023 | -7.98 Mn |
| Jun 30, 2023 | -17.71 Mn |
| Mar 31, 2023 | -113.00 Mn |
| Dec 31, 2022 | -7.58 Mn |
| Sep 30, 2022 | 3.91 Mn |
| Jun 30, 2022 | 81.99 Mn |
| Mar 31, 2022 | -13.99 Mn |
| Dec 31, 2021 | 45.11 Mn |
| Sep 30, 2021 | -3.76 Mn |
| Jun 30, 2021 | 9.06 Mn |